NOVARTIS FDA Approval ANDA 062566

ANDA 062566

NOVARTIS

FDA Drug Application

Application #062566

Application Sponsors

ANDA 062566NOVARTIS

Marketing Status

Discontinued001

Application Products

001OINTMENT;OPHTHALMIC0.1%;EQ 3.5MG BASE/GM;10,000 UNITS/GM0DEXACIDINDEXAMETHASONE; NEOMYCIN SULFATE; POLYMYXIN B SULFATE

FDA Submissions

ORIG1AP1985-02-22
MANUF (CMC); Manufacturing (CMC)SUPPL2AP1996-08-08
MANUF (CMC); Manufacturing (CMC)SUPPL3AP1995-12-15
MANUF (CMC); Manufacturing (CMC)SUPPL4AP1996-07-03
MANUF (CMC); Manufacturing (CMC)SUPPL5AP1996-06-25
MANUF (CMC); Manufacturing (CMC)SUPPL6AP1996-08-08

Submissions Property Types

ORIG1Null0
SUPPL2Null0
SUPPL3Null0
SUPPL4Null0
SUPPL5Null0
SUPPL6Null0

CDER Filings

cder:Array
(
    [0] => Array
        (
            [ApplNo] => 62566
            [companyName] => 
            [docInserts] => ["",""]
            [products] => []
            [labels] => 
            [originalApprovals] => []
            [supplements] => 
            [actionDate] => 0000-00-00
        )

)

© 2026 FDA.report
This site is not affiliated with or endorsed by the FDA.